Access cutting-edge colorectal cancer treatment through this clinical trial at a research site in Golden. Study-provided care at no cost to qualified participants.
Access colorectal cancer specialists in Golden at no cost
This study follows strict safety protocols and ethical guidelines
All study-related colorectal cancer treatment provided free
Colorectal cancer (CRC) is the third most common type of cancer diagnosed worldwide and in China. The purpose of this study is to assess adverse events disease activity when comparing intravenously (IV) infused telisotuzumab adizutecan to trifluridine and tipiracil (LONSURF) oral tablets plus IV infused bevacizumab in adult participants with c-Met protein above cutoff level refractory metastatic colorectal cancer (mCRC). Telisotuzumab adizutecan is an investigational drug being developed for th
Sponsor: AbbVie
Check if you qualify for this colorectal cancer clinical trial in Golden, CO
If you're searching for colorectal cancer treatment options in Golden, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Golden research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colorectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.